These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2299976)

  • 1. Long-term follow-up of hypopituitary patients treated with human growth hormone.
    Libber SM; Plotnick LP; Johanson AJ; Blizzard RM; Kwiterovich PO; Migeon CJ
    Medicine (Baltimore); 1990 Jan; 69(1):46-55. PubMed ID: 2299976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
    Beshyah SA; Henderson A; Niththyananthan R; Skinner E; Anyaoku V; Richmond W; Sharp P; Johnston DG
    J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
    Belgorosky A; Martinez A; Domene H; Heinrich JJ; Bergada C; Rivarola MA
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
    Bozzola M; Lorini R; Schimpff RM; Severi F; Job JC
    Horm Metab Res; 1986 Apr; 18(4):264-7. PubMed ID: 3710421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-heparin plasma lipase activity in hypopituitary adults.
    Beshyah SA; Henderson A; Baynes C; Copping D; Richmond W; Johnston DG
    Horm Res; 1995; 44(2):69-74. PubMed ID: 7590635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).
    Rochira V; Mossetto G; Jia N; Cannavo S; Beck-Peccoz P; Aimaretti G; Ambrosio MR; Di Somma C; Losa M; Ferone D; Lubrano C; Scaroni C; Giampietro A; Corsello SM; Poggi M
    J Endocrinol Invest; 2018 Nov; 41(11):1259-1266. PubMed ID: 29536433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin.
    Smith JC; Lane HA; Lewis J; Dann S; Goodfellow J; Collins P; Evans LM; Scanlon MF; Davies JS
    J Clin Endocrinol Metab; 2003 May; 88(5):2152-6. PubMed ID: 12727969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear growth in hypopituitary patients treated with hGH after age fifteen.
    Pertzelan A; Adler-Bier M; Kauli R; Josefsberg Z; Grunebaum M; Horodniceanu C; Laron Z
    Acta Paediatr Scand Suppl; 1979; 277():69-74. PubMed ID: 295569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.
    Hintz RL; Liu F; Rosenfeld RG; Kemp SF
    J Clin Endocrinol Metab; 1981 Jul; 53(1):100-4. PubMed ID: 6165729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL; Daughaday WH; Weldon VV
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.